Thomas Richard Fuerst, EVP, Chief Scientific Officer at PHARMATHENE, INC (PIP), bought 10,000 shares at $1.51 ($15K) on 2011-11-10, disclosed to the SEC on 2011-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.